Trials / Unknown
UnknownNCT04799730
Expression of CXCR4 in Patients With Systemic Lupus Erythematosus
Study of CD184 in Systemic Lupus Erythematosus
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (estimated)
- Sponsor
- Sohag University · Academic / Other
- Sex
- All
- Age
- 16 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
The objective of this study is to estimate the possible role of CD184 in the pathogenesis of SLE; comparing its level among SLE cases to healthy controls.
Detailed description
Detection of CXCR4 (CD184) expression on CD19+ B cells by flow cytometry in patients of SLE, comparing its level in the development of lupus activity and pathogenic process of SLE internal organ involvement/ mucocutaneus and/or musculoskeletal involvement. Identify this correlation will be useful for clarifying other accessory factors to improve the diagnosis, better treatment strategy, follow up as well as prognosis for these patients
Conditions
Timeline
- Start date
- 2021-05-01
- Primary completion
- 2021-11-01
- Completion
- 2022-05-01
- First posted
- 2021-03-16
- Last updated
- 2021-03-16
Source: ClinicalTrials.gov record NCT04799730. Inclusion in this directory is not an endorsement.